2225 — Jinhai Medical Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$6.59bn
- HK$6.50bn
- SG$45.64m
Annual cashflow statement for Jinhai Medical Technology, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 0.086 | 1.43 | -0.062 | 0.784 | — |
| Depreciation | |||||
| Non-Cash Items | 2.7 | -1.51 | 2.57 | 2.88 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.95 | 4.19 | -1.59 | -0.806 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 7.9 | 7.38 | 3.34 | 4.24 | — |
| Capital Expenditures | -0.647 | -0.138 | -0.607 | -1.18 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.72 | -5.91 | -2.04 | 0.027 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.07 | -6.04 | -2.64 | -1.15 | — |
| Financing Cash Flow Items | -0.436 | -0.314 | -0.132 | 0.109 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.23 | -4.15 | -4.81 | -3.72 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.66 | -3.06 | -3.99 | -0.872 | — |